Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Australian seagulls found to carry antibiotic resistant bacteria
Silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones.
Birds earmarked as potential reservoirs for human disease

Seagulls across Australia carry antibiotic resistant bacteria that cause serious infections in humans, according to new research.

Scientists at Murdoch University, Perth, found that 20 per cent of silver gulls carry bacteria that cause infections such as E.coli, urinary tract infections and sepsis. Study leader Dr Sam Abraham said the problem was prevalent across Australia.

“Seagulls act as ecological sponges (bio-accumulators) and we have earmarked them as a potential reservoir for agents that may cause human disease,” he explained.

The study revealed that silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones. It also found resistance to carbapanem drugs - a class of antibiotics often used for severe infections - in birds from New South Wales and Victoria.

The researchers also found evidence of a seagull in Western Australia carrying resistance to the ‘last resort’ antibiotic, colistin. Study author Dr Mark O’Dea said it was the first time resistance to this drug has been recorded in an Australian wild animal.

“Our results have raised the concern that seagulls could be acquiring this pathogen through their opportunistic feeding habits where they scavenge from leftover human waste and may then be subsequently spreading these resistant bacteria over vast distances,” he said.

“Management of this issue will require examination of human waste sources to determine where gulls are acquiring these elements, and whether or not this can be managed.”

The study, Resistance to critically important antimicrobials in Australian silver gulls (Chroicocephalus novaehollandiae) and evidence of anthropogenic origins, is published in Antimicrobial Chemotherapy.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.